SecBot SecBot
6-K ·Filed Nov 12, 2026

EVAX

Evaxion A/S
NEUTRAL
Impact 2/10
Horizonmonths Processed4d 18h ago SEC0001171843-26-007379
Notable filing: 6-K
Actionable Insight • Neutral

Monitor the March 4, 2027 business update for full-year 2026 financial results and any pipeline or partnership updates. No immediate catalyst from this filing.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$2.77
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.08%
T+1 · $2.74
Vs SPY
−0.72%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $2.77entry
  2. T+1 · 4d ago −1.08%α −0.72% · $2.74
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evaxion A/S filed a Form 6-K announcing its 2027 financial calendar, which includes dates for business updates and financial results for full-year 2026 and each quarter of 2027, as well as its Annual General Meeting. The filing contains no financial results, guidance, or material operational updates.

Key Facts

  • Evaxion announced its 2027 financial calendar on November 12, 2026.
  • Full-year 2026 results will be released on March 4, 2027.
  • Q1 2027 results on May 4, 2027; Q2 on August 19, 2027; Q3 on November 18, 2027.
  • Annual General Meeting scheduled for April 29, 2027.

Financial Impact

No financial data or material event; routine calendar announcement.

Risk Factors

  • No financial or operational content; the filing is purely administrative.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-007379
Exhibit: exh_991.htm0001171843-26-007379
Document: 0001171843-26-007379-index-headers.html0001171843-26-007379
Document: 0001171843-26-007379-index.html0001171843-26-007379
Document: 0001171843-26-007379.txt0001171843-26-007379
Earnings Context (Synthetic; results releases only)0001171843-26-007379

Track record

50 reports on EVAX

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  2. Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  3. Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
  4. Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  5. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  6. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  7. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  8. Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
  9. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
  10. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
Showing 10 of 50

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026